Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francisca Lago

Showing results (61-70 of 150) with videos related to

Pageof 15
Sort By:
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|September 28, 2018
Oleocanthal Inhibits Catabolic and Inflammatory Mediators in LPS-Activated Human Primary Osteoarthritis (OA) Chondrocytes Through MAPKs/NF-κB PathwaysMorena Scotece, Javier Conde, Vanessa Abella, et al.
Plos One|February 25, 2012
Differences in MEF2 and NFAT transcriptional pathways according to human heart failure aetiologyRaquel Cortés, Miguel Rivera, Esther Roselló-Lletí, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|December 17, 2015
The potential of lipocalin-2/NGAL as biomarker for inflammatory and metabolic diseasesVanessa Abella, Morena Scotece, Javier Conde, et al.
Pharmacological Research|May 19, 2024
Adipokines as potential pharmacological targets for immune inflammatory rheumatic diseases: Focus on rheumatoid arthritis, osteoarthritis, and intervertebral disc degenerationYousof Farrag, Mariam Farrag, María Varela-García, et al.
Scientific Reports|April 5, 2016
Human Ischemic Cardiomyopathy Shows Cardiac Nos1 Translocation and its Increased Levels are Related to Left Ventricular PerformanceEsther Roselló-Lletí, Ricardo Carnicer, Estefanía Tarazón, et al.
Frontiers in Physiology|September 5, 2017
Relaxin-2 in Cardiometabolic Diseases: Mechanisms of Action and Future PerspectivesSandra Feijóo-Bandín, Alana Aragón-Herrera, Diego Rodríguez-Penas, et al.
Drug Discovery Today|June 27, 2017
Progranulin as a biomarker and potential therapeutic agentVanessa Abella, Jesús Pino, Morena Scotece, et al.
Scientific Reports|February 9, 2016
The novel adipokine progranulin counteracts IL-1 and TLR4-driven inflammatory response in human and murine chondrocytes via TNFR1Vanessa Abella, Morena Scotece, Javier Conde, et al.
Scientific Reports|August 3, 2016
Protein Inhibitor of NOS1 Plays a Central Role in the Regulation of NOS1 Activity in Human Dilated HeartsEsther Roselló-Lletí, Estefanía Tarazón, Ana Ortega, et al.
European Journal of Heart Failure|October 28, 2016
Changes in human Golgi apparatus reflect new left ventricular dimensions and function in dilated cardiomyopathy patientsEstefanía Tarazón, Esther Roselló-Lletí, Ana Ortega, et al.
Pageof 15

Showing results (61-70 of 150) with videos related to

Sort By:
Pageof 15
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|September 28, 2018
Oleocanthal Inhibits Catabolic and Inflammatory Mediators in LPS-Activated Human Primary Osteoarthritis (OA) Chondrocytes Through MAPKs/NF-κB PathwaysMorena Scotece, Javier Conde, Vanessa Abella, et al.
Plos One|February 25, 2012
Differences in MEF2 and NFAT transcriptional pathways according to human heart failure aetiologyRaquel Cortés, Miguel Rivera, Esther Roselló-Lletí, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|December 17, 2015
The potential of lipocalin-2/NGAL as biomarker for inflammatory and metabolic diseasesVanessa Abella, Morena Scotece, Javier Conde, et al.
Pharmacological Research|May 19, 2024
Adipokines as potential pharmacological targets for immune inflammatory rheumatic diseases: Focus on rheumatoid arthritis, osteoarthritis, and intervertebral disc degenerationYousof Farrag, Mariam Farrag, María Varela-García, et al.
Scientific Reports|April 5, 2016
Human Ischemic Cardiomyopathy Shows Cardiac Nos1 Translocation and its Increased Levels are Related to Left Ventricular PerformanceEsther Roselló-Lletí, Ricardo Carnicer, Estefanía Tarazón, et al.
Frontiers in Physiology|September 5, 2017
Relaxin-2 in Cardiometabolic Diseases: Mechanisms of Action and Future PerspectivesSandra Feijóo-Bandín, Alana Aragón-Herrera, Diego Rodríguez-Penas, et al.
Drug Discovery Today|June 27, 2017
Progranulin as a biomarker and potential therapeutic agentVanessa Abella, Jesús Pino, Morena Scotece, et al.
Scientific Reports|February 9, 2016
The novel adipokine progranulin counteracts IL-1 and TLR4-driven inflammatory response in human and murine chondrocytes via TNFR1Vanessa Abella, Morena Scotece, Javier Conde, et al.
Scientific Reports|August 3, 2016
Protein Inhibitor of NOS1 Plays a Central Role in the Regulation of NOS1 Activity in Human Dilated HeartsEsther Roselló-Lletí, Estefanía Tarazón, Ana Ortega, et al.
European Journal of Heart Failure|October 28, 2016
Changes in human Golgi apparatus reflect new left ventricular dimensions and function in dilated cardiomyopathy patientsEstefanía Tarazón, Esther Roselló-Lletí, Ana Ortega, et al.
Pageof 15